{"id":"https://openalex.org/W2770081072","doi":"https://doi.org/10.1136/jim-2017-000609","title":"Cytokeratin-18 and Enhanced Liver Fibrosis Scores in Type 1 and Type 2 Diabetes and Effects of Two Different Insulins","display_name":"Cytokeratin-18 and Enhanced Liver Fibrosis Scores in Type 1 and Type 2 Diabetes and Effects of Two Different Insulins","publication_year":2017,"publication_date":"2017-11-22","ids":{"openalex":"https://openalex.org/W2770081072","doi":"https://doi.org/10.1136/jim-2017-000609","mag":"2770081072","pmid":"https://pubmed.ncbi.nlm.nih.gov/29167192"},"language":"en","primary_location":{"id":"doi:10.1136/jim-2017-000609","doi":"https://doi.org/10.1136/jim-2017-000609","is_oa":false,"landing_page_url":"https://doi.org/10.1136/jim-2017-000609","pdf_url":null,"source":{"id":"https://openalex.org/S104415515","display_name":"Journal of Investigative Medicine","issn_l":"1081-5589","issn":["1081-5589","1708-8267"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Investigative Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070639714","display_name":"Arun Jayant Sanyal","orcid":"https://orcid.org/0000-0001-8682-5748","observed_orcids":["https://orcid.org/0000-0001-8682-5748"]},"institutions":[{"id":"https://openalex.org/I72019824","display_name":"Virginia Commonwealth University Medical Center","ror":"https://ror.org/057xmsr27","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I72019824"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arun Sanyal","raw_affiliation_strings":["Virginia Commonwealth University Medical Center, Richmond, Virginia, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virginia Commonwealth University Medical Center, Richmond, Virginia, USA","institution_ids":["https://openalex.org/I72019824"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086957117","display_name":"Kenneth J. Cusi","orcid":"https://orcid.org/0000-0002-8629-418X","observed_orcids":["https://orcid.org/0000-0002-8629-418X"]},"institutions":[{"id":"https://openalex.org/I2800717037","display_name":"University of Florida Health","ror":"https://ror.org/04tk2gy88","country_code":"US","type":"education","lineage":["https://openalex.org/I2800717037","https://openalex.org/I33213144"]},{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth Cusi","raw_affiliation_strings":["Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, Florida, USA","institution_ids":["https://openalex.org/I2800717037","https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057894973","display_name":"Mark L. Hartman","orcid":"https://orcid.org/0000-0003-2396-7356","observed_orcids":["https://orcid.org/0000-0003-2396-7356"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark L Hartman","raw_affiliation_strings":["Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100634784","display_name":"Shuyu Zhang","orcid":"https://orcid.org/0000-0003-1419-3635","observed_orcids":["https://orcid.org/0000-0003-1419-3635"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shuyu Zhang","raw_affiliation_strings":["Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061691275","display_name":"Edward J. Bastyr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]},{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward J Bastyr","raw_affiliation_strings":["Division of Endocrinology & Metabolism, Indiana University School of Medicine, Indianapolis, Indiana, USA","Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology & Metabolism, Indiana University School of Medicine, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I4388446366","https://openalex.org/I4394709130"]},{"raw_affiliation_string":"Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046986824","display_name":"Juliana M. Bue\u2010Valleskey","orcid":"https://orcid.org/0000-0002-9746-7744","observed_orcids":["https://orcid.org/0000-0002-9746-7744"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juliana M Bue-Valleskey","raw_affiliation_strings":["Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082380245","display_name":"Annette M. Chang","orcid":"https://orcid.org/0000-0003-0847-0333","observed_orcids":["https://orcid.org/0000-0003-0847-0333"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Annette M Chang","raw_affiliation_strings":["Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040811419","display_name":"Axel Haupt","orcid":"https://orcid.org/0000-0003-4502-0470","observed_orcids":["https://orcid.org/0000-0003-4502-0470"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Axel Haupt","raw_affiliation_strings":["Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110236818","display_name":"Scott J. Jacober","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott J Jacober","raw_affiliation_strings":["Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051170290","display_name":"Robert J. Konrad","orcid":"https://orcid.org/0000-0003-0923-0542","observed_orcids":["https://orcid.org/0000-0003-0923-0542"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert J Konrad","raw_affiliation_strings":["Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024493594","display_name":"Qianyi Zhang","orcid":"https://orcid.org/0000-0003-0973-0037","observed_orcids":["https://orcid.org/0000-0003-0973-0037"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qianyi Zhang","raw_affiliation_strings":["Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058778822","display_name":"Byron J. Hoogwerf","orcid":"https://orcid.org/0000-0001-6014-4151","observed_orcids":["https://orcid.org/0000-0001-6014-4151"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Byron J Hoogwerf","raw_affiliation_strings":["Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA","Lilly Corporate Center, Eli Lilly and Company, Indianapolis, IN 46285,USA"],"raw_orcid":"https://orcid.org/0000-0001-6014-4151","affiliations":[{"raw_affiliation_string":"Lilly Corporate Center, Eli Lilly and Company, Indianapolis, Indiana, USA","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Lilly Corporate Center, Eli Lilly and Company, Indianapolis, IN 46285,USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5058778822"],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":{"value":3900,"currency":"USD","value_usd":3900},"apc_paid":null,"fwci":0.6423,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.71784772,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":97},"biblio":{"volume":"66","issue":"3","first_page":"661","last_page":"668"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytokeratin-18","display_name":"cytokeratin 18","score":0.9950000047683716},{"id":"https://openalex.org/keywords/enhanced-liver-fibrosis-test","display_name":"enhanced liver fibrosis test","score":0.9570000171661377},{"id":"https://openalex.org/keywords/non-alcoholic-fatty-liver-disease","display_name":"non-alcoholic fatty liver disease","score":0.878000020980835},{"id":"https://openalex.org/keywords/type-1-diabetes","display_name":"type 1 diabetes","score":0.9150000214576721},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":1.0},{"id":"https://openalex.org/keywords/insulin-glargine","display_name":"insulin glargine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/basal-insulin","display_name":"basal insulin","score":0.6909999847412109},{"id":"https://openalex.org/keywords/alanine-aminotransferase","display_name":"alanine aminotransferase","score":0.9179999828338623},{"id":"https://openalex.org/keywords/liver-fat-content","display_name":"liver fat","score":0.9769999980926514},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.6119999885559082},{"id":"https://openalex.org/keywords/insulin-treated-patients","display_name":"insulin-treated patients","score":0.49900001287460327}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7858155965805054},{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.7752107381820679},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6991857886314392},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5461654663085938},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.545956015586853},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5386547446250916},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5225595831871033},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.504904568195343},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.4947180449962616},{"id":"https://openalex.org/C2781232474","wikidata":"https://www.wikidata.org/wiki/Q124407","display_name":"Type 1 diabetes","level":3,"score":0.47828707098960876},{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.43001505732536316},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.10476952791213989},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003710","descriptor_name":"Demography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008103","descriptor_name":"Liver Cirrhosis","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D008103","descriptor_name":"Liver Cirrhosis","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050154","descriptor_name":"Adiposity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053538","descriptor_name":"Keratin-18","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1136/jim-2017-000609","doi":"https://doi.org/10.1136/jim-2017-000609","is_oa":false,"landing_page_url":"https://doi.org/10.1136/jim-2017-000609","pdf_url":null,"source":{"id":"https://openalex.org/S104415515","display_name":"Journal of Investigative Medicine","issn_l":"1081-5589","issn":["1081-5589","1708-8267"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Investigative Medicine","raw_type":"journal-article"},{"id":"pmid:29167192","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29167192","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of investigative medicine : the official publication of the American Federation for Clinical Research","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":52,"referenced_works":["https://openalex.org/W1889367418","https://openalex.org/W1920759175","https://openalex.org/W1926691574","https://openalex.org/W1936378503","https://openalex.org/W1963683487","https://openalex.org/W1964108702","https://openalex.org/W1964734498","https://openalex.org/W1967033154","https://openalex.org/W1971238948","https://openalex.org/W1981623819","https://openalex.org/W1983496515","https://openalex.org/W1999023976","https://openalex.org/W1999065994","https://openalex.org/W2005135840","https://openalex.org/W2011275709","https://openalex.org/W2022956561","https://openalex.org/W2025106732","https://openalex.org/W2044136233","https://openalex.org/W2058203033","https://openalex.org/W2060847352","https://openalex.org/W2062618014","https://openalex.org/W2062812115","https://openalex.org/W2073137449","https://openalex.org/W2074203821","https://openalex.org/W2081604210","https://openalex.org/W2087236284","https://openalex.org/W2087484038","https://openalex.org/W2088249096","https://openalex.org/W2111191397","https://openalex.org/W2121514783","https://openalex.org/W2122860085","https://openalex.org/W2134819112","https://openalex.org/W2140467079","https://openalex.org/W2145283527","https://openalex.org/W2157671355","https://openalex.org/W2159469729","https://openalex.org/W2163707858","https://openalex.org/W2168898273","https://openalex.org/W2173136480","https://openalex.org/W2299195034","https://openalex.org/W2319994491","https://openalex.org/W2332481127","https://openalex.org/W2406227915","https://openalex.org/W2469322296","https://openalex.org/W2493194090","https://openalex.org/W2529114944","https://openalex.org/W2530573410","https://openalex.org/W2531213507","https://openalex.org/W2531539547","https://openalex.org/W2606658420","https://openalex.org/W4247078845","https://openalex.org/W4251785080"],"related_works":["https://openalex.org/W2126771093","https://openalex.org/W7221746762","https://openalex.org/W2531213507","https://openalex.org/W2809076816","https://openalex.org/W2334543953","https://openalex.org/W1937606201","https://openalex.org/W2886345282","https://openalex.org/W4240875409","https://openalex.org/W7221010537","https://openalex.org/W2882729766"],"abstract_inverted_index":{"Data":[0],"on":[1],"cytokeratin-18":[2],"(K-18)":[3],"and":[4,33,40,46,54,146,174,191,208,213,220,230,235,246],"enhanced":[5],"liver":[6,17,55],"fibrosis":[7],"(ELF)":[8],"score":[9,176,195,210],"in":[10,36,70,81,92,103,119,121,130,141,151,160,172,180,189,193,215],"insulin-treated":[11,216],"diabetes":[12,43],"patients":[13,217],"with":[14,79,89,117,139,149,211,218,227],"non-alcoholic":[15],"fatty":[16],"disease":[18],"(NAFLD)":[19],"are":[20,238,242],"limited.":[21],"This":[22],"study":[23],"analyzed":[24],"phase":[25],"III":[26],"data":[27,203],"comparing":[28],"basal":[29],"insulin":[30,34],"peglispro":[31],"(BIL)":[32],"glargine":[35],"type":[37,41],"1":[38],"(T1D),":[39],"2":[42],"(T2D)":[44],"(insulin-na\u00efve":[45],"insulin-treated).":[47],"Alanine":[48],"aminotransferase":[49],"(ALT),":[50],"K-18,":[51],"ELF":[52,126,154,175,194,209,231],"scores":[53,127,155,232],"fat":[56],"content":[57],"(LFC),":[58],"measured":[59],"by":[60],"MRI,":[61],"were":[62,128,167,199],"obtained":[63],"longitudinally.":[64],"Baseline":[65,125],"K-18":[66,98,113,207,229],"(U/L)":[67],"was":[68,114],"higher":[69,129],"T2D":[71,93,123,131],"(range:":[72,76,132,136],"207\u2012247)":[73],"than":[74,134],"T1D":[75,135,142,219],"148\u2012183),":[77],"correlated":[78,116,138,148],"ALT":[80,120,140,190,212],"all":[82,185],"populations":[83],"(r":[84,94],"(range)":[85,95],"0.264\u20120.637,":[86],"p<0.05),":[87,145],"but":[88,105,162,233],"LFC":[90,150,173,214],"only":[91,143],"0.474\u20120.586,":[96],"p<0.05).":[97],"increased":[99,156,228],"significantly":[100,115,157],"from":[101,110,158],"baseline":[102,111,159],"BIL-treated,":[104],"not":[106,147,163],"glargine-treated":[107,164],"patients.":[108,165],"Change":[109],"(CFB)":[112],"CFB":[118,171,188,192],"BIL-treated":[122,161,186],"populations.":[124],"9.12\u20129.20)":[133],"8.24\u20128.36),":[137],"(0.209,":[144],"any":[152,181],"population.":[153],"There":[166],"no":[168],"correlations":[169],"between":[170],"at":[177,196],"week":[178,197],"52":[179,198],"treatment":[182],"group/population.":[183],"In":[184],"populations,":[187],"positively":[200],"correlated.":[201],"These":[202],"characterize":[204],"associations":[205],"of":[206],"T2D.":[221],"Hepatopreferential":[222],"insulins":[223],"may":[224],"be":[225],"associated":[226],"mechanisms":[234],"clinical":[236],"significance":[237],"unknown.":[239],"ClinicalTrials.gov":[240],"identifiers":[241],"NCT01481779,":[243],"NCT01435616,":[244],"NCT01454284":[245],"NCT01582451.":[247]},"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-12-04T00:00:00"}